Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | SYK | P43405 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 3/20 | 0.36 |
| ▸ | CTSS | P25774 | 2/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6939530 | 0.87 | MMP8 (0.42) | CTSKMMP1MMP3MMP8CTSL | |
| SCHEMBL6943309 | 0.85 | CTSK (0.41) | CTSKMMP1MMP3MMP9PSMB5 | |
| SCHEMBL6943313 | 0.85 | CTSK (0.41) | CTSKMMP1MMP3MMP9PSMB5 | |
| SCHEMBL6943385 | 0.76 | MMP1 (0.44) | CTSKMMP1MMP3MMP9MMP8 | |
| SCHEMBL27471004 | 0.76 | MMP3 (0.42) | CTSKMMP1MMP3MMP9SYK | |
| SCHEMBL7837093 | 0.74 | MMP1 (0.44) | MMP1MMP3MMP9POLB | |
| SCHEMBL7837095 | 0.74 | MMP1 (0.44) | MMP1MMP3MMP9POLB | |
| SCHEMBL6939522 | 0.74 | MMP1 (0.47) | CTSKMMP1MMP3MMP8CTSL | |
| SCHEMBL6939528 | 0.74 | MMP1 (0.47) | CTSKMMP1MMP3MMP8CTSL | |
| SCHEMBL6659518 | 0.74 | MMP3 (0.45) | CTSKMMP1MMP3MMP9MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0993442-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-04-23 | — | — | EP | disclosed |
| US-6235787-B1 | ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS | HOFFMANN-LA ROCHE INC. | 2001-05-22 | — | — | US | disclosed |